News & Events

News

All categories

Earnings

Press Release

All years

2019

2018

2017

2016

2015

2014

Affimed Announces Third Quarter 2017 Financial Results and Corporate Update Conference Call

October 30, 2017

Affimed to Present at the LEERINK Partners Roundtable Series: Rare Disease & Immuno-Oncology

September 22, 2017

Affimed Appoints Dr. Wolfgang Fischer as Chief Operating Officer

September 13, 2017

Affimed to Present at the 2017 Wells Fargo Healthcare Conference – Boston

September 4, 2017

Affimed Reports Financial Results for Second Quarter 2017

August 1, 2017

Affimed Announces Second Quarter 2017 Financial Results and Corporate Update Conference Call

July 25, 2017

Affimed Presents Preclinical Data on AFM24 and AFM26 at EACR-AACR-SIC 2017

June 27, 2017

Affimed Presents Data on First-in-Class BCMA-Targeting Immune Cell Engager AFM26 at ASCO Annual Meeting 2017

June 6, 2017

Affimed to Present at the Jefferies 2017 Global Healthcare Conference – New York

May 30, 2017

Affimed Announces Annual General Meeting of Shareholders

May 22, 2017

Events

All

Scientific

Investors

20Nov

Jefferies 2019 London Healthcare Conference

November 20 - 21, 2019 (London, UK)
Presenter: Adi Hoess

09Dec

Antibody Engineering & Therapeutics

December 9 - 13, 2019 (San Diego, USA)
Presenter: Michael Tesar

Webcasts
More events

We use cookies to give you the best experience on our website. By continuing to use it, you agree with it.